Injective (INJ)

The Injective price has been trading within a falling wedge and, after reaching the final stages, is juggling around some range. These ranges have been trend reversal zones in the past and hence after a brief consolidation, the price is expected to trigger a minor upswing beyond $20. But the question appears: whether the INJ price sustains above the gains?

After the major fall in the first few days of the month, the INJ price triggered a recovery that seems to remain restricted within a range. The RSI rebounded and reached the average zone but is failing to surpass it. Therefore, it suggests that the INJ price may certainly rise above the consolidation but may soon drop back to the lower support of the wedge, which may place the token at the apex of the consolidation. This could be when the platform witnesses a huge influx of buying volume, which may eventually trigger a bullish rise beyond $26. $INJ